Real-time enrollment status for this hypertension, resistant to conventional therapy clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:42 PM UTC
| NCT Number | NCT06246396 |
| Recruiting Status | Recruiting |
| Condition | Hypertension, Resistant to Conventional Therapy |
| Phase | PHASE4 |
| Target Enrollment | 120 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | March 6, 2026 (Mar 6, 2026) |
As of July 18, 2026: Clinical trial NCT06246396 is currently recruiting participants. This phase4 study for hypertension, resistant to conventional therapy is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06246396 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06246396 was last updated Mar 6, 2026 (March 6, 2026). HelloStudys verifies this status automatically.